Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.

OBJECTIVES The precise epidemiology of childhood pneumonia remains poorly defined. Accurate and prompt etiologic diagnosis is limited by inadequate clinical, radiologic, and laboratory diagnostic methods. The objective of this study was to determine as precisely as possible the epidemiology and morbidity of community-acquired pneumonia in hospitalized children. METHODS Consecutive immunocompetent children hospitalized with radiographically confirmed lower respiratory infections (LRIs) were evaluated prospectively from January 1999 through March 2000. Positive blood or pleural fluid cultures or pneumolysin-based polymerase chain reaction assays, viral direct fluorescent antibody tests, or viral, mycoplasmal, or chlamydial serologic tests were considered indicative of infection by those organisms. Methods for diagnosis of pneumococcal pneumonia among study subjects were published by us previously. Selected clinical characteristics, indices of inflammation (white blood cell and differential counts and procalcitonin values), and clinical outcome measures (time to defervescence and duration of oxygen supplementation and hospitalization) were compared among groups of children. RESULTS One hundred fifty-four hospitalized children with LRIs were enrolled. Median age was 33 months (range: 2 months to 17 years). A pathogen was identified in 79% of children. Typical respiratory bacteria were identified in 60% (of which 73% were Streptococcus pneumoniae), viruses in 45%, Mycoplasma pneumoniae in 14%, Chlamydia pneumoniae in 9%, and mixed bacterial/viral infections in 23%. Preschool-aged children had as many episodes of atypical bacterial LRIs as older children. Children with typical bacterial or mixed bacterial/viral infections had the greatest inflammation and disease severity. Multivariate logistic-regression analyses revealed that high temperature (> or = 38.4 degrees C) within 72 hours after admission (odds ratio: 2.2; 95% confidence interval: 1.4-3.5) and the presence of pleural effusion (odds ratio: 6.6; 95% confidence interval: 2.1-21.2) were significantly associated with bacterial pneumonia. CONCLUSIONS This study used an expanded diagnostic armamentarium to define the broad spectrum of pathogens that cause pneumonia in hospitalized children. The data confirm the importance of S pneumoniae and the frequent occurrence of bacterial and viral coinfections in children with pneumonia. These findings will facilitate age-appropriate antibiotic selection and future evaluation of the clinical effectiveness of the pneumococcal conjugate vaccine as well as other candidate vaccines.

[1]  P. Lebon,et al.  Etiology and response to antibiotic therapy of community-acquired pneumonia in French children , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  M. Leinonen,et al.  Moraxella catarrhalis--an uncommon cause of community-acquired pneumonia in Swedish children. , 1994, Scandinavian journal of infectious diseases.

[3]  S. Razin,et al.  Molecular and diagnostic procedures in mycoplasmology , 1995 .

[4]  S. Megison,et al.  Management of parapneumonic collections in infants and children. , 2000, Journal of pediatric surgery.

[5]  B. Claesson,et al.  Antibody response to outer membrane of noncapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia , 1991, The Pediatric infectious disease journal.

[6]  O. Ruuskanen,et al.  Metapneumovirus and acute wheezing in children , 2002, The Lancet.

[7]  M. Leinonen,et al.  Etiology of childhood pneumonia: serologic results of a prospective, population-based study. , 1998, The Pediatric infectious disease journal.

[8]  O. Ruuskanen,et al.  Etiology of community‐acquired pneumonia in 254 hospitalized children , 2000, The Pediatric infectious disease journal.

[9]  M. Leinonen,et al.  Aetiology of community-acquired pneumonia in children treated in hospital , 2005, European Journal of Pediatrics.

[10]  C. Linton,et al.  Rationalised prescribing for community acquired pneumonia: a closed loop audit , 2000, Archives of disease in childhood.

[11]  M. Granström,et al.  Etiology of community‐acquired pneumonia in children based on antibody responses to bacterial and viral antigens , 1989, The Pediatric infectious disease journal.

[12]  M. Campbell,et al.  Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. , 1998, The Pediatric infectious disease journal.

[13]  K. Mcintosh Community-acquired pneumonia in children. , 2002, The New England journal of medicine.

[14]  M. Leinonen,et al.  Evaluation of serological methods in the diagnosis ofChlamydia pneumoniae pneumonia during an epidemic in Finland , 1993, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  M. Leinonen,et al.  Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. , 1995, The Journal of infectious diseases.

[16]  K. O'Brien,et al.  Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  K. Holmes,et al.  Nongonococcal urethritis and related infections , 1977 .

[18]  P. Saikku,et al.  Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. , 1999, Scandinavian journal of infectious diseases.

[19]  E. Lewis,et al.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia , 2002, The Pediatric infectious disease journal.

[20]  J. Hedrick,et al.  Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. , 1995, The Pediatric infectious disease journal.

[21]  L. Taussig,et al.  Respiratory syncytial virus‐associated lower respiratory illnesses: possible influence of other agents , 1993 .

[22]  O. Ruuskanen,et al.  Pneumonia in childhood: Etiology and response to antimicrobial therapy , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  M. Leinonen,et al.  Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. SE-TU Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  M. Leinonen,et al.  Etiology and treatment of community-acquired pneumonia in ambulatory children. , 1999, The Pediatric infectious disease journal.